CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, has signed a contract for distribution of its Vergenix Flowable Gel product covering Belarus, Kazakhstan, Georgia, Azerbaijan, Armenia and Uzbekistan, it was reported on Monday.

The firm stated that it has received its first order for a fee running into hundreds of thousands of US dollars. According to the terms of the deal, CollPlant will deliver a part of the order immediately and the remainder over the next six months, with the contract covering a five-year period.

The product is based on the firm's rhCollagen technology aimed at treating acute and chronic hard-to-heal wounds including diabetic ulcers, pressure sores, surgical cuts and trauma wounds.